Oncare Hawaii Inc-POB II — Honolulu, Hawaii

Oncare Hawaii Inc-POB II is a clinical research site located in Honolulu, Hawaii, United States 96813.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Oncare Hawaii Inc-POB II has participated in 25 clinical trials with 2 currently active.

Therapeutic areas: Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer.

Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncare Hawaii Inc-POB II?

Oncare Hawaii Inc-POB II has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncare Hawaii Inc-POB II conducted?

Oncare Hawaii Inc-POB II has 25 clinical trials on record, with 2 currently active. Their work covers Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer.

Is Oncare Hawaii Inc-POB II accredited by Crixeo Health?

Yes — Oncare Hawaii Inc-POB II holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Oncare Hawaii Inc-POB II?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.